PEAK6 Group’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-5,800
Closed -$323K 4700
2018
Q1
$323K Sell
5,800
-52,800
-90% -$2.89M ﹤0.01% 2981
2017
Q4
$3.13M Buy
58,600
+15,600
+36% +$736K 0.01% 1098
2017
Q3
$1.85M Buy
43,000
+27,900
+185% +$1.33M 0.01% 1455
2017
Q2
$912K Buy
+15,100
New +$895K 0.01% 2002
2017
Q1
Sell
-4,400
Closed -$293K 4703
2016
Q4
$293K Sell
4,400
-1,200
-21% -$78.1K ﹤0.01% 2995
2016
Q3
$371K Sell
5,600
-200
-3% -$13.7K ﹤0.01% 2606
2016
Q2
$420K Buy
5,800
+700
+14% +$48.1K ﹤0.01% 2522
2016
Q1
$330K Buy
+5,100
New +$338K ﹤0.01% 2671
2015
Q4
Sell
-3,000
Closed -$230K 5060
2015
Q3
$230K Buy
+3,000
New +$242K ﹤0.01% 3612
2014
Q2
Sell
-38,000
Closed -$2.35M 4912
2014
Q1
$2.35M Buy
38,000
+30,000
+375% +$1.75M 0.02% 1146
2013
Q4
$427K Sell
8,000
-1,200
-13% -$64.4K ﹤0.01% 2814
2013
Q3
$231K Sell
9,200
-454,400
-98% -$22.2M ﹤0.01% 3561
2013
Q2
$21.2K Buy
+463,600
New +$20.8M 0.08% 91

Other funds holding MD

PEAK6 Group's MD Position: Q2 2018 in Review

PEAK6 Group reduced its Pediatrix Medical (MD) stake by 64% in Q2 2018, selling an estimated $528K and leaving 6,259 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #3108.

PEAK6 Group first reported a position in MD in Q2 2013 and has held it in 11 quarters since. The position peaked at $2.11M in Q3 2013. 322 funds tracked by Wall St. Rank hold MD as of Q2 2018.

  • PEAK6 Group held 6,259 shares of Pediatrix Medical worth $271K as of Q2 2018.
  • PEAK6 Group sold 11,011 Pediatrix Medical shares in Q2 2018, an estimated $528K.
  • Pediatrix Medical made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #3108 holding.
  • PEAK6 Group first reported a position in Pediatrix Medical in Q2 2013 and has held it in 11 quarters since.
  • PEAK6 Group's Pediatrix Medical position peaked at $2.11M in Q3 2013.
  • 322 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.